National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -6 of 6         results per page
 View Search Criteria | Help With Results
           
Last Modified: 12/6/2007     First Published: 9/23/2005  

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Treatment
Active
18 and over
NCI
CHNMC-04090
NCT00233948

Last Modified: 5/22/2008     First Published: 12/24/2007  

2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
UPCC-806285
806285, UPCC-04507, NCT00589056


3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Treatment
Approved-not yet active
18 and over
Other
MEC 07-03-026
NCT00704600

Last Modified: 10/23/2007     First Published: 2/12/2007  

4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
NCI-07-C-0047
NCI-P6880, NCT00436735

First Published: 6/24/2008  

5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Active
19 and over
NCI
UNMC-44107
441-07, UNMC-441-07-FB, NCT00705393


6.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Approved-not yet active
18 to 65
Other
07-09-04/07
EudraCT number 2008-001078-34, NCT00694837

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov